Efficacy and Safety of Fermented Cinnamon Vine Powder on Decrement of Body Fat
- Conditions
- Obesity
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Fermented Cinnamon Vine Powder
- Registration Number
- NCT01734187
- Lead Sponsor
- Chonbuk National University Hospital
- Brief Summary
The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Fermented Cinnamon Vine Powde on decrement of body fat. The investigators measured decrement of body fat parameters , including abdominal fat, Body Fat Mass, LDL-C, HDL-C, Total Cholesterol and triglyceride, and monitored their blood pressure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Males and females 19-55 years old
- BMI(body mass index) ≥ 25 kg/m^2 or WC(Waist Circumference) ≥ 90(men), WC ≥ 85(women)
- Able to give informed consent
- Significant variation in weight(more 10%) in the past 3 months
- Allergic or hypersensitive to any of the ingredients in the test products
- History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
- History of alcohol or substance abuse
- Participation in any other clinical trials within past 2 months
- Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
- Pregnant or lactating women etc.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Placebo - Fermented Cinnamon Vine Powder Fermented Cinnamon Vine Powder -
- Primary Outcome Measures
Name Time Method Changes in Body Fat Mass 12 weeks Body Fat Mass was measured in study visit 1(0 week) and visit 3(12 week).
Changes in abdominal Fat 12 weeks Abdominal Fat was measured in study visit 1(0 week) and visit 3(12 week).
- Secondary Outcome Measures
Name Time Method Changes in LDL-cholesterol(Low Density Lipoprotein - Cholesterol) 12 weeks LDL-C(Low Density Lipoprotein - cholesterol) was measured in study visit 1(0 week) and visit 3(12 week).
Changes in HDL-Cholesterol(High Density Lipoprotein - Cholesterol) 12 weeks HDL-cholesterol(High Density Lipoprotein - cholesterol) was measured in study visit 1(0 week) and visit 3(12 week).
Changes in total cholesterol 12 weeks Total cholesterol was measured in study visit 1(0 week) and visit 3(12 week).
Changes in Triglycerides 12 weeks Triglyceride was measured in study visit 1(0 week) and visit 3(12 week).
Trial Locations
- Locations (1)
Clinical Trial Center for Functional Foods; Chonbuk National University Hospital
🇰🇷Jeonju, Jeollabuk-do, Korea, Republic of